Korro Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $84,534,000.

Profit Margin

Korro Bio, Inc. (NASDAQ:KRRO): Profit margin
2017 0 -20.23M
2019 28.94M -18.74M -64.76%
2020 36.98M -26.51M -71.68%
2021 14.06M -21.95M -156.09%
2022 0 -58.03M
2023 0 -81.17M

KRRO Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2017
Revenue
Revenue
0014.06M36.98M28.94M0
Cost of revenue
3.63M2.51M3.84M1.58M16.81M531K
Gross profit
-3.63M-2.51M10.22M35.40M12.13M-531K
Operating exp.
Research and development
57.25M42.20M23.80M36.65M18.33M11.78M
Selling and marketing
000000
Total operating expenses
84.53M58.99M35.49M62.95M32.80M15.77M
Operating income
-84.53M-58.99M-35.49M-27.55M-20.67M-16.30M
Other income (expenses), net
3.38M976K13.53M1.07M1.92M-3.93M
Income before tax
-81.14M-58.02M-21.95M-26.47M-18.74M-20.23M
Income tax expense
27K10K2K35K01
Net income
-81.17M-58.03M-21.95M-26.51M-18.74M-20.23M
Earnings per share
Basic EPS
-53.09-227.58-4.94-41.1-30.39-32.27
Diluted EPS
-53.08-227.42-4.94-41.1-30.39-32.27